Geron Corp (NASDAQ: GERN) is -10.45% lower on its value in year-to-date trading and has touched a low of $1.64 and a high of $5.34 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The GERN stock was last observed hovering at around $3.42 in the last trading session, with the day’s loss setting it -0.25%.
Currently trading at $3.17, the stock is -11.05% and -17.66% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 17.94 million and changing -7.31% at the moment leaves the stock -22.94% off its SMA200. GERN registered 47.44% gain for a year compared to 6-month loss of -33.40%. The firm has a 50-day simple moving average (SMA 50) of $3.8498 and a 200-day simple moving average (SMA200) of $4.11365.
The stock witnessed a -20.35% gain in the last 1 month and extending the period to 3 months gives it a -24.88%, and is -11.94% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 5.34% over the week and 4.81% over the month.
Geron Corp (GERN) has around 141 employees, a market worth around $1.92B and $29.48M in sales. Profit margin for the company is -682.48%. Distance from 52-week low is 93.29% and -40.64% from its 52-week high. The company has generated returns on investments over the last 12 months (-65.53%).
with sales reaching $59.01M over the same period.The EPS is expected to grow by 18.41% this year, but quarterly earnings will post 37,898.68% year-over-year. Quarterly sales are estimated to grow 256,447.83% in year-over-year returns.
Geron Corp (GERN) Top Institutional Holders
338.0 institutions hold shares in Geron Corp (GERN), with institutional investors hold 85.45% of the company’s shares. The shares outstanding are 603.10M, and float is at 564.66M with Short Float at 11.52%. Institutions hold 85.38% of the Float.
The top institutional shareholder in the company is BLACKROCK INC. with over 46.55 million shares valued at $197.38 million. The investor’s holdings represent 7.7138% of the GERN Shares outstanding. As of 2024-06-30, the second largest holder is RA CAPITAL MANAGEMENT, L.P. with 46.2 million shares valued at $195.9 million to account for 7.6558 of the shares outstanding. The other top investors are VANGUARD GROUP INC which holds 31.93 million shares representing 5.2914% and valued at over $135.4 million, while VIVO CAPITAL, LLC holds 4.5113 of the shares totaling 27.23 million with a market value of $115.44 million.
Geron Corp (GERN) Insider Activity
The most recent transaction is an insider sale by GRETHLEIN ANDREW J, the company’s EVP, Chief Operating Officer. SEC filings show that GRETHLEIN ANDREW J sold 674,348 shares of the company’s common stock on Jul 08 ’24 at a price of $4.56 per share for a total of $3.07 million. Following the sale, the insider now owns 0.0 shares.
Geron Corp disclosed in a document filed with the SEC on Jun 10 ’24 that Feller Faye (EVP, Chief Medical Officer) sold a total of 287,900 shares of the company’s common stock. The trade occurred on Jun 10 ’24 and was made at $4.63 per share for $1.33 million. Following the transaction, the insider now directly holds 0.0 shares of the GERN stock.
Still, SEC filings show that on Jun 10 ’24, Kapur Anil (EVP, Corp Strategy & CCO) disposed off 421,875 shares at an average price of $4.64 for $1.96 million. The insider now directly holds 0 shares of Geron Corp (GERN).
